| pubmed-article:2852938 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2852938 | lifeskim:mentions | umls-concept:C0949945 | lld:lifeskim |
| pubmed-article:2852938 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:2852938 | lifeskim:mentions | umls-concept:C0205147 | lld:lifeskim |
| pubmed-article:2852938 | lifeskim:mentions | umls-concept:C0033684 | lld:lifeskim |
| pubmed-article:2852938 | lifeskim:mentions | umls-concept:C0030956 | lld:lifeskim |
| pubmed-article:2852938 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:2852938 | lifeskim:mentions | umls-concept:C0872192 | lld:lifeskim |
| pubmed-article:2852938 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:2852938 | lifeskim:mentions | umls-concept:C0678594 | lld:lifeskim |
| pubmed-article:2852938 | lifeskim:mentions | umls-concept:C0205164 | lld:lifeskim |
| pubmed-article:2852938 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:2852938 | pubmed:dateCreated | 1989-4-18 | lld:pubmed |
| pubmed-article:2852938 | pubmed:abstractText | Earlier we found that the immune response and antiviral protection from FMDV can be achieved by immunization with uncoupled FMDV peptides. In a search of approaches to animal protection from FMDV A22 strain we prepared a series of peptides corresponding to the putative antigenic determinants. Synthetic 131-149 and 140-149 sequences afforded 50 to 80% protection, both in the free state and conjugated with keyhole limpet hemocyanin. We believe that the 140-149 segment is so far the smallest peptide capable of eliciting specific antiviral protection without conjugation with a high molecular carrier. | lld:pubmed |
| pubmed-article:2852938 | pubmed:language | rus | lld:pubmed |
| pubmed-article:2852938 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2852938 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2852938 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2852938 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2852938 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2852938 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2852938 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2852938 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2852938 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:2852938 | pubmed:issn | 0132-3423 | lld:pubmed |
| pubmed-article:2852938 | pubmed:author | pubmed-author:IvanovV TVT | lld:pubmed |
| pubmed-article:2852938 | pubmed:author | pubmed-author:ChepurkinA... | lld:pubmed |
| pubmed-article:2852938 | pubmed:author | pubmed-author:Vol'pinaO MOM | lld:pubmed |
| pubmed-article:2852938 | pubmed:author | pubmed-author:Surovo?A... | lld:pubmed |
| pubmed-article:2852938 | pubmed:author | pubmed-author:Ul'iashinV... | lld:pubmed |
| pubmed-article:2852938 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2852938 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:2852938 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2852938 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2852938 | pubmed:pagination | 1363-71 | lld:pubmed |
| pubmed-article:2852938 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2852938 | pubmed:meshHeading | pubmed-meshheading:2852938-... | lld:pubmed |
| pubmed-article:2852938 | pubmed:meshHeading | pubmed-meshheading:2852938-... | lld:pubmed |
| pubmed-article:2852938 | pubmed:meshHeading | pubmed-meshheading:2852938-... | lld:pubmed |
| pubmed-article:2852938 | pubmed:meshHeading | pubmed-meshheading:2852938-... | lld:pubmed |
| pubmed-article:2852938 | pubmed:meshHeading | pubmed-meshheading:2852938-... | lld:pubmed |
| pubmed-article:2852938 | pubmed:meshHeading | pubmed-meshheading:2852938-... | lld:pubmed |
| pubmed-article:2852938 | pubmed:meshHeading | pubmed-meshheading:2852938-... | lld:pubmed |
| pubmed-article:2852938 | pubmed:meshHeading | pubmed-meshheading:2852938-... | lld:pubmed |
| pubmed-article:2852938 | pubmed:meshHeading | pubmed-meshheading:2852938-... | lld:pubmed |
| pubmed-article:2852938 | pubmed:meshHeading | pubmed-meshheading:2852938-... | lld:pubmed |
| pubmed-article:2852938 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:2852938 | pubmed:articleTitle | [Antigenic structure of the foot-and-mouth disease virus. II. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth disease virus type A22]. | lld:pubmed |
| pubmed-article:2852938 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2852938 | pubmed:publicationType | English Abstract | lld:pubmed |
